The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F13%3A00070583" target="_blank" >RIV/00216224:14110/13:00070583 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15110/13:33143920 RIV/65269705:_____/13:#0002106
Result on the web
<a href="http://dx.doi.org/10.1038/leu.2013.171" target="_blank" >http://dx.doi.org/10.1038/leu.2013.171</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/leu.2013.171" target="_blank" >10.1038/leu.2013.171</a>
Alternative languages
Result language
angličtina
Original language name
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
Original language description
The introduction of tyrosine kinase inhibitors (TKI) in the treatment of Philadelphia chromosome-positive (Ph_) chronic myeloid leukemia (CML) has revolutionized the outcome, but the prognosis of the disease is still based on prognostic systems that weredeveloped in the era of conventional chemotherapy and interferon (IFN)-alfa. A new prognostic score including only two variables, spleen size and basophils, was developed for the prediction of complete cytogenetic response (CCyR) and progression-free survival (PFS). The score was based on a large series of patients who were enrolled in prospective multicenter studies of first-line imatinib treatment. The prognostic value of the EUTOS (European Treatment and Outcome Study for CML) score has now been tested in an independent, multicenter, multinational series of 1288 patients who were treated first-line with imatinib outside prospective studies.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia
ISSN
0887-6924
e-ISSN
—
Volume of the periodical
27
Issue of the periodical within the volume
10
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
2016-2022
UT code for WoS article
000325642600008
EID of the result in the Scopus database
—